Q8NEB9 PK3C3_HUMAN
Gene name: PIK3C3
Protein name: Phosphatidylinositol 3-kinase catalytic

List of molecules and drugs that interact with protein Q8NEB9

# DrugDomain Data PBD ligand DrugBank Accession PubChem ChEMBL Name Drug action Affinity data
1 Q8NEB9_1TT 1TT n/a 137347993 n/a (8S)-9-[(5-chloranylpyridin-3-yl)methyl]-2-[(3R)-3-methylmorpholin-4-yl]-8-(trifluoromethyl)-6,7,8,9a-tetrahydro-3H-pyrimido[1,2-a]pyrimidin-4-one n/a
2 Q8NEB9_2UG 2UG n/a 67983123 CHEMBL3781415 4'-(cyclopropylmethyl)-N~2~-(pyridin-4-yl)-4,5'-bipyrimidine-2,2'-diamine n/a
3 Q8NEB9_5QS 5QS n/a 67983918 CHEMBL3781466 1-[[4-(cyclopropylmethyl)-5-[2-(pyridin-4-ylamino)pyrimidin-4-yl]pyrimidin-2-yl]amino]-2-methyl-propan-2-ol n/a
4 Q8NEB9_7A5 7A5 n/a 72709284 CHEMBL4586628 (8S)-2-[(3R)-3-methylmorpholin-4-yl]-9-(3-methyl-2-oxobutyl)-8-(trifluoromethyl)-6,7,8,9-tetrahydro-4H-pyrimido[1,2-a]pyrimidin-4-one n/a
5 Q8NEB9_7IH 7IH n/a 157049302 CHEMBL5183804 N-{4-[(7R,8R)-4-oxo-7-(propan-2-yl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazin-2-yl]pyridin-2-yl}cyclopropanecarboxamide n/a
6 Q8NEB9_7IK 7IK n/a 157049303 CHEMBL5193287 (7R,8R)-2-[(3R)-3-methylmorpholin-4-yl]-7-(propan-2-yl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4(5H)-one n/a
7 Q8NEB9_7IQ 7IQ n/a 157049304 CHEMBL5207217 (5aS,8aR,9S)-2-[(3R)-3-methylmorpholin-4-yl]-5,5a,6,7,8,8a-hexahydro-4H-cyclopenta[e]pyrazolo[1,5-a]pyrazin-4-one n/a
8 Q8NEB9_AJZ AJZ n/a 9901372 CHEMBL510164 3-(4-morpholin-4-ylthieno[3,2-d]pyrimidin-2-yl)phenol n/a
9 Q8NEB9_CL CL n/a 312 n/a CHLORIDE ION n/a
10 Q8NEB9_EDO EDO n/a 174 CHEMBL457299 1,2-ETHANEDIOL n/a
11 Q8NEB9_EUT EUT n/a 49854502 CHEMBL4536855 (8S)-9-[3,5-bis(fluoranyl)phenyl]-2-morpholin-4-yl-8-(trifluoromethyl)-7,8-dihydro-6H-pyrimido[1,2-a]pyrimidin-4-one n/a
12 Q8NEB9_GOL GOL DB09462 753 CHEMBL692 GLYCEROL n/a
13 Q8NEB9_H2E H2E n/a 138753227 CHEMBL4745255 2-morpholin-4-yl-6-[7-[(2~{R})-1-morpholin-4-ylpropan-2-yl]oxy-9~{H}-thioxanthen-4-yl]pyran-4-one n/a
14 Q8NEB9_JXM JXM n/a 49853890 CHEMBL4536755 (8S)-9-[(2R)-2-hydroxy-2-phenylethyl]-2-(morpholin-4-yl)-8-(trifluoromethyl)-6,7,8,9-tetrahydro-4H-pyrimido[1,2-a]pyrimidin-4-one n/a
15 Q8NEB9_NA NA n/a 923 n/a SODIUM ION n/a
16 Q8NEB9_OZ8 OZ8 n/a 155884468 CHEMBL4873212 4-morpholin-4-yl-6-[(2~{R})-2-(phenylmethyl)pyrrolidin-1-yl]-1~{H}-pyridin-2-one n/a
17 Q8NEB9_PGE PGE DB02327 8172 CHEMBL1235259 TRIETHYLENE GLYCOL n/a
18 Q8NEB9_RBQ RBQ n/a 57406937 CHEMBL4470174 (8S)-2-(morpholin-4-yl)-9-[2-(propan-2-yloxy)ethyl]-8-(trifluoromethyl)-6,7,8,9-tetrahydro-4H-pyrimido[1,2-a]pyrimidin-4-one n/a
19 Q8NEB9_SO4 SO4 DB14546 1117 n/a SULFATE ION n/a
20 Q8NEB9_UJB UJB n/a 86278575 n/a (2S)-1-[(5-chloro-2-thienyl)methyl]-8-[(3R,5R)-3,5-dimethylmorpholin-4-yl]-2-(trifluoromethyl)-3,4-dihydro-2H-pyrimido[1,2-a]pyrimidin-6-one n/a
21 Q8NEB9_093 093 DB06836 6852167 CHEMBL1229535 N-(5-{4-Chloro-3-[(2-hydroxyethyl)sulfamoyl]phenyl}-4-methyl-1,3-thiazol-2-yl)acetamide n/a IC50(nM) = 307.0
22 Q8NEB9_DB11962 n/a DB11962 n/a n/a GSK-1059615 inhibitor